You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Claims for Patent: 10,927,129

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,927,129

Title:	N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a- -hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity
Abstract:	The present invention is directed to N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11- a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide of the formula: ##STR00001## or a pharmaceutically acceptable salt or stereoisomer thereof, and pharmaceutical compositions comprising the same. The present invention has HIV integrase inhibitory activity.
Inventor(s):	Johns; Brian A. (Research Triangle Park, NC), Kawasuji; Takashi (Osaka, JP), Taishi; Teruhiko (Osaka, JP), Taoda; Yoshiyuki (Osaka, JP)
Assignee:	SHINOGI & CO., LTD. (Osaka, JP) VIIV HEALTHCARE COMPANY (Research Triangle Park, NC)
Application Number:	16/400,373
Patent Claims:	1. A compound: ##STR00201## or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent together with the compound according to claim 1, or a pharmaceutically acceptable salt thereof. 3. A compound: ##STR00202## 4. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent together with the compound according to claim 3. 5. A compound: ##STR00203## 6. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent together with the compound according to claim 5. 7. A compound: ##STR00204## or a pharmaceutically acceptable salt thereof. 8. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent together with the compound according to claim 7, or a pharmaceutically acceptable salt thereof. 9. A compound: ##STR00205## 10. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent together with the compound according to claim 9. 11. A compound: ##STR00206## 12. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent together with the compound according to claim 11.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.